Novel Actions of Tissue-Type Plasminogen Activator in Chronic Kidney Disease

Frontiers in Bioscience - Landmark - United States
doi 10.2741/3073
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers in Bioscience

Related search

Plasminogen Activator Inhibitor-1 in Chronic Kidney Disease: Evidence and Mechanisms of Action

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2006English

The Tissue-Type Plasminogen Activator Story

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2009English

Thrombolysis of Canine Femoral Artery Thrombus by a Novel Modified Tissue-Type Plasminogen Activator (E6010).

The Japanese Journal of Pharmacology
1994English

Role of Tissue-Type Plasminogen Activator in Remodeling of the Ductus Arteriosus

Circulation Reports
2020English

4766075 Human Tissue Plasminogen Activator

Biotechnology Advances
Applied MicrobiologyBiotechnologyBioengineering
1989English

Tissue-Type Plasminogen Activator: A Role for O-Linked Fucose.

Journal of Clinical Investigation
Medicine
1994English

Human Visceral Adipose Tissue and the Plasminogen Activator Inhibitor Type 1

International Journal of Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2007English

Highly Stable Plasminogen Activator Inhibitor Type One (VLHL PAI-1) Protects Fibrin Clots From Tissue Plasminogen Activator-Mediated Fibrinolysis

International Journal of Molecular Medicine
MedicineGenetics
2007English

Coronary Thrombolysis With Facilitated Absorption of Intramuscularly Injected Tissue-Type Plasminogen Activator.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy